abril 18, 2007

Noticias médicas

Vacina para a gripe das aves
FDA Approves Human Vaccine for Avian Influenza
The FDA yesterday approved a human vaccine against the H5N1 influenza virus, marking the first such approval in the U.S.
In a press release the agency said that, should H5N1 develop the ability to spread readily from person to person, "the vaccine may provide early limited protection in the months before a vaccine tailored to the pandemic strain of the virus could be developed and produced." The vaccine will be kept in a federal stockpile and available only through public health officials; it is approved for those 18 to 64 who are at increased risk for H5N1 exposure.

Sem comentários: